Trial intelligence / Profile preview

Tofogliflozin Drug-Drug Interaction Study (2) in Healthy Adult Males

jRCT2080221710Phase 1

Sponsor
Chugai Pharmaceutical Co., Ltd.
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, single-arm trial of tofogliflozin in type 2 diabetes mellitus (T2DM), sponsored by Chugai Pharmaceutical Co., Ltd.

02

Drugs

tofogliflozin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on jRCT2080221710.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2080221710.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call